We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Linked to Destruction of Mitochondria in Huntington's Disease

By LabMedica International staff writers
Posted on 28 Sep 2016
Print article
Image: The structure of the VCP protein (Photo courtesy of Wikimedia Commons).
Image: The structure of the VCP protein (Photo courtesy of Wikimedia Commons).
Researchers studying the molecular mechanisms involved in Huntington's disease (HD) have identified a protein that binds to mutant huntingtin protein in the mitochondria of neurons, which results in destruction of the mitochondria and death of the nerve cells.

Huntington’s disease is caused by a dominant gene that encodes the huntingtin protein. The 5' end of the HD gene has a sequence of three DNA bases, cytosine-adenine-guanine (CAG), coding for the amino acid glutamine that is repeated multiple times. Normal persons have a CAG repeat count of between seven and 35 repeats, while the mutated form of the gene has anywhere from 36 to 180 repeats. The mutant form of huntingtin is broken down into toxic peptides, which contribute to the pathology of the syndrome.

Investigators at Case Western Reserve University (Cleveland, OH, USA) have been searching for factors that interact with mutant huntingtin protein to better understand the initial steps of Huntington’s disease progression. To this end they conducted proteomic analyses, which identified valosin-containing protein (VCP) as a mutant huntingtin-binding protein on the mitochondria.

VCP is an ATPase enzyme present in all eukaryotes. Its main function is to segregate protein molecules from large cellular structures such as protein assemblies, organelle membranes, and chromatin, and thus facilitate the degradation of released polypeptides by the multi-subunit protease proteasome.

The investigators reported in the August 26, 2016, online edition of the journal Nature Communications that VCP was selectively translocated to the mitochondria, where it was bound to mutant huntingtin protein in various HD models. VCP accumulated in mitochondria elicited excessive mitophagy (degradation of the mitochondria) and caused neuronal cell death.

Blocking huntingtin/VCP mitochondrial interaction with a peptide, HV-3, abolished VCP translocation to the mitochondria, corrected excessive mitophagy, and reduced cell death in HD mouse- and patient-derived cells and HD transgenic mouse brains. Treatment with HV-3 reduced behavioral and neuropathological phenotypes of HD in both fragment- and full-length huntingtin transgenic mice. These findings demonstrated a causal role of mutant huntingtin-induced VCP mitochondrial accumulation in HD pathogenesis and suggested that the peptide HV-3 might be a useful tool for developing new therapeutics to treat HD.

“Because mitochondrial dysfunction has been proposed to play an important role in the pathogenesis of Huntington’s disease, we investigated the binding proteins of mutant huntingtin on mitochondria,” said senior author Dr. Xin Qi, assistant professor of physiology and biophysics at Case Western Reserve University. “We found that VCP is a key player in mitochondria-associated autophagy, a mitochondria self-eating process. Over-accumulation of VCP on mitochondria thus results in a great loss of mitochondria, which leads to neuronal cell death due to lack of energy supply.”

Related Links:
Case Western Reserve University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.